In situ BCL2 expression is an independent prognostic factor in HIV‐associated DLBCL, a LYMPHOVIR cohort study-Reference-Cited by-同舟云学术

In situ BCL2 expression is an independent prognostic factor in HIV‐associated DLBCL, a LYMPHOVIR cohort study

Published:2019-08-29 Issue:3 Volume:188 Page:413-423
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Philippe Laure¹²^ORCID,Lancar Remi³,Laurent Camille⁴⁵,Algarte‐Genin Michele³,Chassagne‐Clément Catherine⁶,Fabiani Bettina⁷,Pierre Chenard Marie⁸,Lazure Thierry⁹¹⁰,Parrens Marie¹¹,Charlotte Frederic¹²,Delattre Claire¹³,Gibault Laure¹⁴,Capron Frederique¹⁵,Goubin‐Versini Isabelle¹⁶,Petitjean Bruno¹⁶,Boué François⁹¹⁷,Mounier Nicolas¹⁸,Costello Regis¹⁹^ORCID,Costagliola Dominique³,Prevot Sophie⁹¹⁰,Besson Caroline¹²²⁰^ORCID,

Affiliation:

1. Unit of Haematology-Oncology Centre Hospitalier Versailles Le ChesnayFrance

2. Université Versailles Saint Quentin en Yvelines, Paris‐Saclay University, Communauté Paris‐Saclay Saint-Quentin en YvelinesFrance

3. INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (IPLESP) Sorbonne Université Paris France

4. Department of Pathology Institut Universitaire du Cancer‐Oncopole, CHU Toulouse Toulouse France

5. INSERM, U.1037 Centre de Recherche en Cancérologie de Toulouse‐Purpan Toulouse France

6. Department of Pathology Centre Léon Bérard Lyon France

7. Department of Pathology Hôpital Saint Antoine, AP‐HP Paris France

8. Department of Pathology Hôpital de Hautepierre, University Hospital of Strasbourg Strasbourg France

9. Faculté de médecine Paris Sud Université Paris Sud Le Kremlin‐Bicêtre France

10. Department of Pathology AP‐HP, Hôpitaux Paris Sud, Paris Sud University Le Kremlin-Bicetre France

11. Department of Pathology Haut‐Lévêque Hospital, Southern Hospital Group, Bordeaux University Hospital Pessac France

12. Department of Pathology Hopital Pitie‐Salpetriere and Sorbonne University Paris France

13. Department of Pathology CHRU Lille Lille France

14. Department of Pathology Hôpital Européen Georges Pompidou, AP‐HP, and Université Paris Descartes Paris France

15. Department of Pathology, Faculté de médecine Pierre‐et‐Marie‐Curie Hopital Pitié‐Salpêtrière, AP‐HP Paris France

16. Department of Pathology René DUBOS Hospital Cergy‐Pontoise France

17. Clinical Immunology Unit AP‐HP, Hôpitaux Paris Sud Site Béclère Clamart France

18. Department of Onco‐Haematology Archet Hospital Nice France

19. Department of Haematology AP‐HM, Assistance Publique Hôpitaux de Marseille Marseille France

20. INSERM U1018 Centre pour la Recherche en Epidémiologie et Santé des Populations (CESP), Equipe “Générations et Santé” Gustave Roussy Villejuif France

Funder

INSERM Agence Nationale de Recherche sur le Sida et les Hépatites

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16176

Reference76 articles.

1. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy

2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

3. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy

4. The t(14;18) is associated with germinal center‐derived diffuse large B‐cell lymphoma and is a strong predictor of outcome;Barrans S.L.;Clinical Cancer Research,2003

5. Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Still Far to Go With Characterisation of Molecular and Genetic Features of Diffuse Large B-Cell Lymphoma in People Living With HIV: A Scoping Review;Oncology Reviews;2024-04-19

2. Genetic and phenotypic characterisation of HIV ‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications;Histopathology;2022-10-04

3. Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis;Viruses;2022-09-22

4. Hypoalbuminemia predicts inferior outcome in patients with AIDS-related lymphoma;Infectious Agents and Cancer;2022-06-18

5. Clinical and Molecular Properties of Human Immunodeficiency Virus-Related Diffuse Large B-Cell Lymphoma;Frontiers in Oncology;2021-04-29